{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:59:34Z","timestamp":1760147974972},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nove Nordisk Foundation","award":["NNF170C0026778"],"award-info":[{"award-number":["NNF170C0026778"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The pathogenesis of malaria is associated with blood-stage infection and there is strong evidence that antibodies specific to parasite blood-stage antigens can control parasitemia. This provides a strong rational for applying blood-stage antigen components in a multivalent vaccine, as the induced antibodies in combination can enhance protection. The <jats:italic>Plasmodium falciparum<\/jats:italic> rhoptry-associated membrane antigen (PfRAMA) is a promising vaccine target, due to its fundamental role in merozoite invasion and low level of polymorphism. Polyclonal antibodies against PfRAMA are able to inhibit <jats:italic>P. falciparum<\/jats:italic> growth and interact synergistically when combined with antibodies against <jats:italic>P. falciparum<\/jats:italic> reticulocyte-binding protein 5 (PfRh5) or cysteine-rich protective antigen (PfCyRPA). In this study, we identified a novel PfRAMA-specific mAb with neutralizing activity, which in combination with PfRh5- or PfCyRPA-specific mAbs potentiated the neutralizing effect. By applying phage display technology, we mapped the protective epitope to be in the C-terminal region of PfRAMA. Our results confirmed previous finding of synergy between PfRAMA-, PfRh5- and PfCyRPA-specific antibodies, thereby paving the way of testing these antigens (or fragments of these antigens) in combination to improve the efficacy of blood-stage malaria vaccines. The results emphasize the importance of directing antibody responses towards protective epitopes, as the majority of anti-PfRAMA mAbs were unable to inhibit merozoite invasion of erythrocytes.<\/jats:p>","DOI":"10.1038\/s41598-022-06921-1","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T11:03:09Z","timestamp":1645614189000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Enhancing neutralization of Plasmodium falciparum using a novel monoclonal antibody against the rhoptry-associated membrane antigen"],"prefix":"10.1038","volume":"12","author":[{"given":"Anne S.","family":"Knudsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit P.","family":"Agullet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasper H.","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria R.","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Barfod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"6921_CR1","unstructured":"World Health Organization. World Malaria Report 2020,, https:\/\/www.who.int\/publications\/i\/item\/9789240015791 (2020)."},{"key":"6921_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.chom.2017.07.003","volume":"22","author":"AF Cowman","year":"2017","unstructured":"Cowman, A. F., Tonkin, C. J., Tham, W. H. & Duraisingh, M. T. The molecular basis of erythrocyte invasion by malaria parasites. Cell Host Microbe 22, 232\u2013245. https:\/\/doi.org\/10.1016\/j.chom.2017.07.003 (2017).","journal-title":"Cell Host Microbe"},{"key":"6921_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004670","volume":"11","author":"GE Weiss","year":"2015","unstructured":"Weiss, G. E. et al. Revealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytes. PLoS Pathog. 11, e1004670. https:\/\/doi.org\/10.1371\/journal.ppat.1004670 (2015).","journal-title":"PLoS Pathog."},{"issue":"Pt 3","key":"6921_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1017\/s0031182099006320","volume":"121","author":"LH Bannister","year":"2000","unstructured":"Bannister, L. H., Hopkins, J. M., Fowler, R. E., Krishna, S. & Mitchell, G. H. Ultrastructure of rhoptry development in Plasmodium falciparum erythrocytic schizonts. Parasitology 121(Pt 3), 273\u2013287. https:\/\/doi.org\/10.1017\/s0031182099006320 (2000).","journal-title":"Parasitology"},{"key":"6921_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1083\/jcb.77.1.72","volume":"77","author":"M Aikawa","year":"1978","unstructured":"Aikawa, M., Miller, L. H., Johnson, J. & Rabbege, J. Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. J. Cell Biol. 77, 72\u201382. https:\/\/doi.org\/10.1083\/jcb.77.1.72 (1978).","journal-title":"J. Cell Biol."},{"key":"6921_CR6","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.23239","author":"ES Sherling","year":"2017","unstructured":"Sherling, E. S. et al. The Plasmodium falciparum rhoptry protein RhopH3 plays essential roles in host cell invasion and nutrient uptake. Elife https:\/\/doi.org\/10.7554\/eLife.23239 (2017).","journal-title":"Elife"},{"key":"6921_CR7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.23217","author":"NA Counihan","year":"2017","unstructured":"Counihan, N. A. et al. Plasmodium falciparum parasites deploy RhopH2 into the host erythrocyte to obtain nutrients, grow and replicate. Elife https:\/\/doi.org\/10.7554\/eLife.23217 (2017).","journal-title":"Elife"},{"key":"6921_CR8","doi-asserted-by":"publisher","first-page":"e12733","DOI":"10.1111\/cmi.12733","volume":"19","author":"S Ghosh","year":"2017","unstructured":"Ghosh, S. et al. The Plasmodium rhoptry associated protein complex is important for parasitophorous vacuole membrane structure and intraerythrocytic parasite growth. Cell. Microbiol. 19, e12733. https:\/\/doi.org\/10.1111\/cmi.12733 (2017).","journal-title":"Cell. Microbiol."},{"key":"6921_CR9","doi-asserted-by":"publisher","first-page":"14815","DOI":"10.1074\/jbc.M109.080770","volume":"285","author":"D Richard","year":"2010","unstructured":"Richard, D. et al. Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites. J. Biol. Chem. 285, 14815\u201314822. https:\/\/doi.org\/10.1074\/jbc.M109.080770 (2010).","journal-title":"J. Biol. Chem."},{"key":"6921_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pt.2007.12.002","volume":"24","author":"EJ Remarque","year":"2008","unstructured":"Remarque, E. J., Faber, B. W., Kocken, C. H. & Thomas, A. W. Apical membrane antigen 1: A malaria vaccine candidate in review. Trends Parasitol. 24, 74\u201384. https:\/\/doi.org\/10.1016\/j.pt.2007.12.002 (2008).","journal-title":"Trends Parasitol."},{"key":"6921_CR11","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1074\/jbc.M307859200","volume":"279","author":"AE Topolska","year":"2004","unstructured":"Topolska, A. E., Lidgett, A., Truman, D., Fujioka, H. & Coppel, R. L. Characterization of a membrane-associated rhoptry protein of Plasmodium falciparum. J. Biol. Chem. 279, 4648\u20134656. https:\/\/doi.org\/10.1074\/jbc.M307859200 (2004).","journal-title":"J. Biol. Chem."},{"key":"6921_CR12","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1073\/pnas.85.14.5195","volume":"85","author":"JA Smythe","year":"1988","unstructured":"Smythe, J. A. et al. Identification of two integral membrane proteins of Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 85, 5195\u20135199. https:\/\/doi.org\/10.1073\/pnas.85.14.5195 (1988).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"6921_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008049","volume":"15","author":"ES Sherling","year":"2019","unstructured":"Sherling, E. S. et al. The Plasmodium falciparum rhoptry bulb protein RAMA plays an essential role in rhoptry neck morphogenesis and host red blood cell invasion. PLoS Pathog. 15, e1008049. https:\/\/doi.org\/10.1371\/journal.ppat.1008049 (2019).","journal-title":"PLoS Pathog."},{"key":"6921_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000328","volume":"5","author":"D Richard","year":"2009","unstructured":"Richard, D. et al. Identification of rhoptry trafficking determinants and evidence for a novel sorting mechanism in the malaria parasite Plasmodium falciparum. PLoS Pathog. 5, e1000328. https:\/\/doi.org\/10.1371\/journal.ppat.1000328 (2009).","journal-title":"PLoS Pathog."},{"key":"6921_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.605367","volume":"10","author":"D Ito","year":"2020","unstructured":"Ito, D. et al. Identification of a novel RAMA\/RON3 Rhoptry protein complex in Plasmodium falciparum merozoites. Front. Cell. Infect. Microbiol. 10, 605367. https:\/\/doi.org\/10.3389\/fcimb.2020.605367 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"6921_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1086\/432550","volume":"192","author":"CP Nixon","year":"2005","unstructured":"Nixon, C. P. et al. Antibodies to rhoptry-associated membrane antigen predict resistance to Plasmodium falciparum. J. Infect. Dis. 192, 861\u2013869. https:\/\/doi.org\/10.1086\/432550 (2005).","journal-title":"J. Infect. Dis."},{"key":"6921_CR17","doi-asserted-by":"publisher","first-page":"12045","DOI":"10.1073\/pnas.1702944114","volume":"114","author":"LY Bustamante","year":"2017","unstructured":"Bustamante, L. Y. et al. Synergistic malaria vaccine combinations identified by systematic antigen screening. Proc. Natl. Acad. Sci. U.S.A. 114, 12045\u201312050. https:\/\/doi.org\/10.1073\/pnas.1702944114 (2017).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"6921_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243943","volume":"15","author":"MR Walker","year":"2020","unstructured":"Walker, M. R. et al. Acquisition and decay of IgM and IgG responses to merozoite antigens after Plasmodium falciparum malaria in Ghanaian children. PLoS ONE 15, e0243943. https:\/\/doi.org\/10.1371\/journal.pone.0243943 (2020).","journal-title":"PLoS ONE"},{"key":"6921_CR19","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1128\/iai.72.6.3325-3330.2004","volume":"72","author":"AE Topolska","year":"2004","unstructured":"Topolska, A. E., Richie, T. L., Nhan, D. H. & Coppel, R. L. Associations between responses to the rhoptry-associated membrane antigen of Plasmodium falciparum and immunity to malaria infection. Infect. Immun. 72, 3325\u20133330. https:\/\/doi.org\/10.1128\/iai.72.6.3325-3330.2004 (2004).","journal-title":"Infect. Immun."},{"key":"6921_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.molbiopara.2007.06.001","volume":"155","author":"P Kar","year":"2007","unstructured":"Kar, P., Dash, A. P. & Supakar, P. C. Polymorphism study of rhoptry associated membrane antigen (RAMA) gene of Plasmodium falciparum: A putative vaccine candidate. Mol. Biochem. Parasitol. 155, 156\u2013160. https:\/\/doi.org\/10.1016\/j.molbiopara.2007.06.001 (2007).","journal-title":"Mol. Biochem. Parasitol."},{"key":"6921_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1475-2875-13-93","volume":"13","author":"ZA Zenonos","year":"2014","unstructured":"Zenonos, Z. A., Rayner, J. C. & Wright, G. J. Towards a comprehensive Plasmodium falciparum merozoite cell surface and secreted recombinant protein library. Malar. J. 13, 93. https:\/\/doi.org\/10.1186\/1475-2875-13-93 (2014).","journal-title":"Malar. J."},{"key":"6921_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","volume":"178","author":"DGW Alanine","year":"2019","unstructured":"Alanine, D. G. W. et al. Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies. Cell 178, 216-228.e221. https:\/\/doi.org\/10.1016\/j.cell.2019.05.025 (2019).","journal-title":"Cell"},{"key":"6921_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716305","author":"AS Knudsen","year":"2021","unstructured":"Knudsen, A. S. et al. Strain-dependent inhibition of erythrocyte invasion by monoclonal antibodies against Plasmodium falciparum CyRPA. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.716305 (2021).","journal-title":"Front. Immunol."},{"key":"6921_CR24","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.4049\/jimmunol.1103177","volume":"188","author":"AM Dreyer","year":"2012","unstructured":"Dreyer, A. M. et al. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen. J. Immunol. 188, 6225\u20136237. https:\/\/doi.org\/10.4049\/jimmunol.1103177 (2012).","journal-title":"J. Immunol."},{"key":"6921_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002991","volume":"8","author":"AR Williams","year":"2012","unstructured":"Williams, A. R. et al. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: Assessing combinations of antibodies against PfRH5 and other merozoite antigens. PLoS Pathog 8, e1002991. https:\/\/doi.org\/10.1371\/journal.ppat.1002991 (2012).","journal-title":"PLoS Pathog"},{"key":"6921_CR26","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1128\/JCM.01226-15","volume":"53","author":"CJ Woodrow","year":"2015","unstructured":"Woodrow, C. J. et al. Comparison between flow cytometry, microscopy, and lactate dehydrogenase-based enzyme-linked immunosorbent assay for Plasmodium falciparum drug susceptibility testing under field conditions. J. Clin. Microbiol. 53, 3296\u20133303. https:\/\/doi.org\/10.1128\/JCM.01226-15 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"6921_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/1475-2875-8-294","volume":"8","author":"S Karl","year":"2009","unstructured":"Karl, S., Wong, R. P., St Pierre, T. G. & Davis, T. M. A comparative study of a flow-cytometry-based assessment of in vitro Plasmodium falciparum drug sensitivity. Malar. J. 8, 294. https:\/\/doi.org\/10.1186\/1475-2875-8-294 (2009).","journal-title":"Malar. J."},{"key":"6921_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.149","volume":"3","author":"J Foucquier","year":"2015","unstructured":"Foucquier, J. & Guedj, M. Analysis of drug combinations: current methodological landscape. Pharmacol. Res. Perspect. 3, e00149. https:\/\/doi.org\/10.1002\/prp2.149 (2015).","journal-title":"Pharmacol. Res. Perspect."},{"key":"6921_CR29","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1128\/aac.48.11.4097-4102.2004","volume":"48","author":"QL Fivelman","year":"2004","unstructured":"Fivelman, Q. L., Adagu, I. S. & Warhurst, D. C. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob. Agents Chemother. 48, 4097\u20134102. https:\/\/doi.org\/10.1128\/aac.48.11.4097-4102.2004 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6921_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41541-020-0158-9","volume":"5","author":"M Tamborrini","year":"2020","unstructured":"Tamborrini, M. et al. Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models. NPJ Vaccines 5, 9. https:\/\/doi.org\/10.1038\/s41541-020-0158-9 (2020).","journal-title":"NPJ Vaccines"},{"key":"6921_CR31","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/s41467-019-09894-4","volume":"10","author":"AD Douglas","year":"2019","unstructured":"Douglas, A. D. et al. A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates. Nat. Commun. 10, 1953. https:\/\/doi.org\/10.1038\/s41467-019-09894-4 (2019).","journal-title":"Nat. Commun."},{"key":"6921_CR32","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.immuni.2015.02.012","volume":"42","author":"MJ Boyle","year":"2015","unstructured":"Boyle, M. J. et al. Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria. Immunity 42, 580\u2013590. https:\/\/doi.org\/10.1016\/j.immuni.2015.02.012 (2015).","journal-title":"Immunity"},{"key":"6921_CR33","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41467-019-08528-z","volume":"10","author":"L Reiling","year":"2019","unstructured":"Reiling, L. et al. Targets of complement-fixing antibodies in protective immunity against malaria in children. Nat. Commun. 10, 610. https:\/\/doi.org\/10.1038\/s41467-019-08528-z (2019).","journal-title":"Nat. Commun."},{"key":"6921_CR34","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1128\/IAI.00145-16","volume":"84","author":"DL Hill","year":"2016","unstructured":"Hill, D. L. et al. Merozoite antigens of Plasmodium falciparum elicit strain-transcending opsonizing immunity. Infect. Immun. 84, 2175\u20132184. https:\/\/doi.org\/10.1128\/IAI.00145-16 (2016).","journal-title":"Infect. Immun."},{"key":"6921_CR35","doi-asserted-by":"publisher","first-page":"ofv044","DOI":"10.1093\/ofid\/ofv044","volume":"2","author":"RW Tiendrebeogo","year":"2015","unstructured":"Tiendrebeogo, R. W. et al. Antibody-dependent cellular inhibition is associated with reduced risk against febrile malaria in a longitudinal cohort study involving ghanaian children. Open Forum Infect Dis 2, ofv044. https:\/\/doi.org\/10.1093\/ofid\/ofv044 (2015).","journal-title":"Open Forum Infect Dis"},{"key":"6921_CR36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4049\/jimmunol.1300778","volume":"191","author":"JS Richards","year":"2013","unstructured":"Richards, J. S. et al. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. J. Immunol. 191, 795\u2013809. https:\/\/doi.org\/10.4049\/jimmunol.1300778 (2013).","journal-title":"J. Immunol."},{"key":"6921_CR37","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01566-20","author":"I Campeotto","year":"2020","unstructured":"Campeotto, I. et al. The structure of the cysteine-rich domain of Plasmodium falciparum P113 Identifies The Location Of the RH5 binding site. MBio https:\/\/doi.org\/10.1128\/mBio.01566-20 (2020).","journal-title":"MBio"},{"key":"6921_CR38","doi-asserted-by":"publisher","first-page":"14378","DOI":"10.1073\/pnas.1009198107","volume":"107","author":"MJ Boyle","year":"2010","unstructured":"Boyle, M. J. et al. Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc. Natl. Acad. Sci. U.S.A. 107, 14378\u201314383. https:\/\/doi.org\/10.1073\/pnas.1009198107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"6921_CR39","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1128\/iai.73.6.3677-3685.2005","volume":"73","author":"EM Malkin","year":"2005","unstructured":"Malkin, E. M. et al. Phase 1 clinical trial of apical membrane antigen 1: An asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect. Immun. 73, 3677\u20133685. https:\/\/doi.org\/10.1128\/iai.73.6.3677-3685.2005 (2005).","journal-title":"Infect. Immun."},{"key":"6921_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1475-2875-7-45","volume":"7","author":"C Ribaut","year":"2008","unstructured":"Ribaut, C. et al. Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species. Malar. J. 7, 45. https:\/\/doi.org\/10.1186\/1475-2875-7-45 (2008).","journal-title":"Malar. J."},{"key":"6921_CR41","first-page":"221","volume-title":"Immunological Methods\u2014(15) Plasmodium Falciparum Malaria Parasite Cultures and Their Use in Immunology","author":"H Matile","year":"1990","unstructured":"Matile, H., Richard, J. & Pink, L. Immunological Methods\u2014(15) Plasmodium Falciparum Malaria Parasite Cultures and Their Use in Immunology 221\u2013234 (Academic Press, 1990)."},{"key":"6921_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/toxins10060236","volume":"10","author":"L Ledsgaard","year":"2018","unstructured":"Ledsgaard, L., Kilstrup, M., Karatt-Vellatt, A., McCafferty, J. & Laustsen, A. H. Basics of antibody phage display technology. Toxins 10, 236. https:\/\/doi.org\/10.3390\/toxins10060236 (2018).","journal-title":"Toxins"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06921-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06921-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06921-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T23:22:23Z","timestamp":1669332143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06921-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6921"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-06921-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3040"}}